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AIR TRANSPORT AND LOGISTICS IN PANDEMIC
OUTBREAK OF INFLUENZA A (H1N1) VIRUS
ABSTRACT
In April 2009, the WHO, (World Health Organization)
evaluated the available data on the swine influenza A (H1N1),
confirmed the outbreak and declared decision on raising the
pandemic phase from five to six. IATA, (International Air
Transport Association) invited the airlines to support WHO’s
reference laboratories around the world in handling specimens
should the outbreak expand further. The specimens shall be
transported according to the regulations stipulated for accep-
tance and transportation of dangerous goods by air. The paper
analyses the current infrastructural situation at the airports in
Croatia, predispositions related to the trained staff and coordi-
nation procedures with the relevant institutions. The imple-
mentation of activities complying with the international regula-
tions are suggested in order to conduct measures fighting the
pandemic in Croatia.
KEY WORDS
pandemic outbreak, regulation, recommendation, specimen,
responsibilities, transportation and logistic for biological sub-
stances
1. INTRODUCTION
Influenza (the flu) is an acute infectious disease of
the respiratory system caused by one of the influenza
viruses. It occurs in the form of larger or smaller epi-
demics and pandemics. Clinically, along with high
temperature during two to five days, the most com-
mon symptoms are general tiredness and weakness,
respiratory symptoms are usually not strong, but the
tendency to complications is especially present in
older persons and persons suffering from other dis-
eases. The influenza viral particles are transmitted by
coughs or sneezes. They are typically transmitted by
air, via large drops of nasal secretions, in close contact
within closed areas. The infected person emits while
talking, sneezing, coughing small droplets into the en-
vironment, which may contain viral particles. These
droplets may then reach another person and enter
their organism through the mucous membrane of the
nose and/or mouth. They may also be transmitted in
direct contact with the infected person and the in-
fected items.
Influenza is caused by one of the three influenza vi-
ruses: Influenzavirus A, Influenzavirus B and Influenza-
virus C from the family Orthomyxoviridae. On their
surface they have two antigens – proteins hemaggluti-
nin (H) and neuraminidase (N), 10-12nm long. They
allow numerous variations i. e. changes in the antigen
structure and they occur almost every year. This is how
new subtypes of the influenza viruses are formed. New
influenza viruses are constantly produced due to the
mutations and reassortment of gens. Mutations can
cause small changes in the hemagglutinin and neura-
midase antigens on the virus surface. This is called an-
tigenic drift, responsible for the creation of new host
species. When the new virus variant achieves greater
capability and becomes dominant it “flies through”
the human population – often sporadic cases and lim-
ited epidemics.
On the other hand, by genetic reassortment the vi-
ruses may acquire new antigens, e. g. recombination of
gens between animal and human species. This is anti-
genic shift. If a human influenza virus occurs with new,
unknown antigens, everybody will be susceptible. The
new flu will expand without control, causing epidem-
ics/pandemics.
Sixteen HA subtypes and nine NA subtypes have
been known. Various combinations of HA and NA
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proteins are possible. Only some influenza subtypes
are in general circulation among people (H1N1,
H1N2, H3N2). Other subtypes have been found in
other animal species. E. g. H7N7 and H3N8 viruses
cause disease in horses, and H3N8 also in dogs. It is
precisely these changes that make it impossible to de-
velop permanent immunity to influenza; if antibodies
are developed one year for a certain type of the flu vi-
rus, they will probably provide no protection against a
new type of flue in another year. Three types of influ-
enzaviruses A, B and C, apart from the antigenic
structure differ also according to their epidemic po-
tential. Influenzavirus A has the highest epidemic po-
tential and it is the “most unpredictable” one since its
surface antigens change most frequently. The latter vi-
rus occurs as the cause of all the pandemics and larger
epidemics. Virus B has the lowest epidemic potential,
i. e. antigenic variations occur less frequently, whereas
these changes occur very rarely in case of virus C.
Also, the influenzaviruses differ regarding the severity
of disease they cause. Influenzavirus A causes more
severe disease, influenzavirus B less severe, and influ-
enzavirus C very mild disease which may even pass
without being recognized.
In the revision of the description of the pandemics
phases in 2009, WHO retained the six phases, incorpo-
rating new recommendations and approaches to the
already existing national recommendations and plans.
The first
The first three phases define the procedures and
actions regarding the preparedness to act in case of
the onset of a pandemic, whereas phases four and six
call for concrete measures to be undertaken in imple-
menting the plan for the defence against the pan-
demic. Two phases represented in Figure 1 after the
fifth, i. e. sixth phase refer to the post-pandemic han-
dling and evaluation of the situation.
The phases differ also regarding the potential of
the influenza virus to cause infection and to “skip” to
other biological species, i. e. to cause epidemics and/or
pandemics. In nature, the influenzavirus circulates
continuously among animals, especially birds. Al-
though such a virus can theoretically develop into a
pandemic virus, in Phase 1 no such virus has been de-
scribed as the cause of infections in humans. In Phase
2 the animal influenzavirus circulates among domestic
and wild animals, causes infections in humans and
there is potential threat of a pandemics. In Phase 3 an-
imal or human-animal influenza reassorted virus
causes random cases or infections in small human
communities, but there is no transmission from hu-
man to human to such an extent to have an outbreak
of infection within a wider community. The limitation
of the transmission from human to human may appear
e. g. in closed communities where there is contact be-
tween the infected person and a member of the closest
family. The limited transmissions within closed com-
munities do not mean that the virus will pass to the
higher phase and cause a pandemics in the wider com-
munity. Phase 4 is characterized by the proven trans-
mission of the animal influenzavirus from human to
human or the proof of an a human-animal influenza
reassorted virus within the community. If such a case is
suspected or confirmed, every state should immedi-
ately consult the World Health Organization in order
to make decisions on further activities. Phase 4 shows
significant increase in the risk of pandemics, but this
does not necessarily mean pandemics itself.
Phase 5 is characterised by the spreading of the vi-
ral infection from human to human in at least two
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Figure 1 – Phases of preparedness and response to outbreak of pandemic, June 2009
Source: WHO; Weekly epidemiological record, No. 25; 19 June 2009
countries within one region. Proclaiming phase 5
means strong warning of a pandemic threat, and in-
vites prompt action regarding organization, communi-
cation, and implementation of the planned measures
to mitigate the consequences. Phase 6 of the pandem-
ics is characterised by the spreading of infection in at
least one country of another region. When this phase
is proclaimed it means that the global pandemics is
present. Adequate control of its spreading can prevent
or at lease mitigate the occurrence of a new wave.
According to the definitions of contagious diseases
defined by the Croatian National Institute of Public
Health, and adopted on the basis of the European
Commission document1, the onset of influenza has
been defined through three segments:
– clinical description or clinical picture compatible with
the flu and characterized by the sudden onset of the
disease, cough, fever, muscle ache, headache, and in-
creased temperature (over 38°C);
– laboratory criterion for the diagnosis has been de-
fined by laboratory certificate in one of the follow-
ing three ways:
– influenza antigen finding or RNA specific for
influenza finding;
– isolation of the influenza virus;
– evidence of response specific for serum
anti-body to influenza A or B.
– Classification of the influenza virus case occur-
rence is contained in three basic categories:
– Possible: not applied;
– Probable: clinically compatible case with epide-
miological relation;
– Confirmed: laboratory confirmed clinical case.
The central institution for the control and moni-
toring of epidemiological diseases in the Republic of
Croatia is the epidemiology unit of the Croatian Na-
tional Institute of Public Health. Its function is cen-
tralized monitoring and control of the disease, and
from this aspect it has the character of a national cen-
tre for disease control. The unit acts as part of the au-
thorities contained in the Act on Health Care and the
Act on the Protection of the Population against Com-
municable Diseases. The scope of the unit’s activities
covers also the procedures and tasks of monitoring
and analysis of the epidemiological situation on the
territory of Croatia, proposal of anti-epidemiological
measures and supervision of their implementation,
coordination, and implementation of the cooperation
between the county institutes for public health, and
cooperation with the department for emergency situa-
tions of the Ministry of Health. The scope of epidemi-
ological control contains the activities and procedures
towards persons suffering of contagious disease as
well as towards persons that had contact with the dis-
eased person. The supervision and epidemiological
control will be carried out also over persons who ar-
rived from the area in which the influenza has been ev-
idenced.
Under the conditions of global pandemic out-
break, the role of reference laboratories of the World
Health Organization in timely confirmation of the vi-
rus presence within a certain geographical area is of
crucial importance in area localization and applica-
tion of adequate measures fighting the virus. Taking
samples from persons who are suspected to have the
virus in order to determine the presence of the virus as
well as sending of specimens to reference laboratory
centres is very significant for further timely undertak-
ing of protective measures. Because of the high speed
at which the pandemic spreads, it is to be expected
that the specimens of the potentially diseased persons
will be exchanged using air transport. Short time pe-
riod after taking the specimens until receiving the ref-
erence finding is of crucial significance in the pan-
demic control and further undertaking of adequate
measures.
2. AIR TRANSPORT AND PANDEMIC,
CAUSE-EFFECT RELATION
One of the most frequent modes of fast epidemic
spreading and occurrence of pandemic is precisely air
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H3N2 1.3-1.6 <0.2% 1-4 million All age groups -0.4 to (-1.5)
Source: WHO; Pandemic Influenza Preparedness and Response, Geneva, Switzerland, April 2009.
transport. Because of emphasized capability of over-
coming large distances within a short period of time,
air transport represents potentially significant threat
to the control and localization of the virus within a cer-
tain area. Often the carriers of epidemiological dis-
eases in the first phases of investigation are sought
precisely in passengers who have arrived from the po-
tentially infected areas by aircraft.
The aircraft air circulation system also represents
potentially favourable environment for the spreading
of airborne viruses. Airborne diseases as well as indi-
cations and risks related to their onset are defined in
the WHO document entitled “International Travel
and Health 2009”. This document defines airborne
transmission of diseases with the following definition:
“Airborne transmission occurs when droplet nuclei (eva-
porated droplets) <5 micron in size are disseminated in
the air. These droplet nuclei can remain suspended in the
air for some time. Droplet nuclei are the residuals of
droplets and when suspended in the air, they dry and pro-
duce particles ranging in size from 1–5 microns.” The vi-
rus droplets are transmitted via nose or mouth mu-
cous membrane provided there is close contact with
the infected person. Virus droplets are absorbed by
breath intake while coughing or sneezing of the in-
fected person.
Tourist trips are related to certain geographic re-
gions during a certain season which may contribute to
fast spreading of the virus from a certain area. At the
same time, virus transmission from one geographic
and climatic area to another can have influence on the
virus image in the new environment. The prevention
and protection against influenzas can thus be made
additionally difficult by the occurrence of new sub-
types of viruses from another geographic environ-
ment. The initial measures to control the spread of the
epidemic i. e. pandemic can be recognized precisely at
airports in a whole series of the for-the-given-moment
adequate procedures. Surveying and registration of
passengers arriving from potentially contagious areas,
establishing of direct testing at airports all the way to
accommodation of passengers in quarantines.
Another aspect of the relation between air trans-
port and pandemic spread can be recognized in the
need to transport specimens taken from the diseased
or potentially infected persons in order to determine
the presence of a virus. In such circumstances the
character of air transport and its ability to overcome
huge distances within a short period of time has al-
most no alternative in practice. Here, attention should
be directed to the basic characteristics of the transport
entity as well as the valid national and international
provisions regulated for the transport of this type of
entity.
Finally, air transport represents the key transport
mode for the pandemic preventive vaccines. Large
quantities of vaccines transported within the shortest
time possible are the precondition to fast and efficient
response to a pandemic. Attention should be also di-
rected to the character of the vaccine as transport en-
tity recognizing strict national and international regu-
lations defined in documents on good production and
distribution practice.
3. CHARACTER OF BIOLOGICAL
PHARMACEUTICAL PRODUCTS
AS TRANSPORT ENTITIES
Transport entities previously known as clinical
specimens, diagnostic specimens or blood samples
and preparations, are regulated and defined by com-
ing into force of the new regulation published in the
IATA Dangerous Goods Regulations, 48th Edition,
of 1 January 2007. All the mentioned categories are
combined under the title of biological substances with
the latter being even possibly restrictive compared to
the valid regulations related to transport. Apart from
the mentioned classification, the classification of the
biological substances was also published by ICAO (In-
ternational Civil Aviation Organization), according to
the key presented in Figure 2.
Biological samples are materials or pharmaceuti-
cal products of human or animal origin. Unlike chemi-
cal pharmaceutical products which include drugs and
medical preparations for human use produced by
chemical processes, biologically produced
pharmaceuticals are characterized precisely by the bi-
ological environment of the production. In the ICAO
document Technical instructions for the safe transport
of dangerous goods by air, 2007-2008 Edition, biologi-
cal substances are defined as specimens of human or
animal origin collected by secretion or extraction di-
rectly from the patient, human or animal, in the form
of blood or its components, physiological secretion,
tissue, parts of body or organs being transported for
purposes such as diagnosis, research activities, or the
needs of medical treatment and prevention of various
diseases.
Isolated from the biological production environ-
ment, the specimens are time and temperature sensi-
tive. This is precisely the reason why they represent a
complex and demanding transport entity. Regarding
time, the biological products are characterized by
disposability and non-reproducibility of the original
form of production, and a short lifecycle. Therefore,
they are sensitive also to exposure to temperature os-
cillations different from the production ones, at the
same time not limited only to the latter.
Temperature distribution regimes depend on the type
of biological products as transport entities. The biological
substances, for instance, can be transported at tempera-
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tures from deepfreeze conditions at -70°C, to ambient
temperature ranging from +15°C to +25°C. Vaccine as
biological pharmaceutical product is distributed mainly
in the range of positive temperature values with possible
temperature excursions even up to +30°C without, condi-
tionally speaking, influence on the vaccine quality.
Should vaccine be exposed at the same time to tempera-
ture of 0°C or lower, its quality is questionable and this
may result in the recall of the vaccine from the market.
The conditions of distributing biological substances or
vaccines as well as temperature ranges to which a product
can be exposed in the distribution environment are de-
fined by the producer respecting the findings of stability
studies.
According to data from the year 2007 Zagreb Air-
port occupied a significant place in the traffic of bio-
logical substances in the Republic of Croatia, with a
total of 1052 biological substances handled in export.
The calculation based on 12 months a year and the av-
erage of 21 workdays in a month, indicates the average
of approximately four shipments per day. The latter
calculation can be presented in a more precise form if
exact dates of every single shipment and the seasonal
characteristic present in this case as well are taken into
consideration. The figure of four biological substances
a day shipped from Zagreb Airport during 2007, when
there was no officially proclaimed threat of pandemic
in the environment, may indicate the presence of a sig-
nificant degree of frequency in the transport of biolog-
ical substances in Croatia. Here the consideration may
include also the character of the shipped biological
substances, in order to obtain a more concrete picture
and profile of shipments. Based on the frequency con-
siderations regarding single shippers at certain ship-
ment frequency it may be concluded that the ship-
ments were mostly the result of research carried out
regarding implementation of a preparation on a target
group of patients. More precise data on the number of
specimens within a defined period of time cannot be
presented due to the confidentiality of data related to
the sponsored studies. It remains to be concluded that
in regular circumstances, when there is no potential
threat of pandemic outbreak of a certain virus, the ma-
jority of treated biological substances may be assigned
to clinical studies.
4. TECHNOLOGY OF HANDLING
BIOLOGICAL PHARMACEUTICALS
The responsibilities of each single mentality
within the technological process of transporting bio-
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Samples for classification
Have any pathogens been neutralized?
Is it known not to contain infectious substances?
Are any micro-organisms present non-pathogenic for humans/animals?
Is it a dried bloodspot/fecal occult blood?
Is it an environmental samples e.g. food and water?
Is it for transplant / transfusion?
Yes
Not subject to the
provisions of the ICAO
Technical Instructions
No
Is it a Category A
substance?
Is it a patient specimen



















Figure 2 – Classification of biological substances
Source: ICAO document; Technical instruction for the Safe Transport of Dangerous Goods by Air, Annex 2, 2005-2006
logical substances have been defined by IATA Dan-
gerous Goods Regulations speaking about biological
substances, or by the Perishable Cargo Regulations
considering vaccines. By considering the distributive
environment one may recognise several phases of the
technological process of transportation. The prepa-
ration phases are characterized by procedures within
the area of the responsibility of the shipper, and re-
fer to the declaration of entities, packing, implemen-
tation and recognition of all the valid national and
international regulatory liabilities in the area of dis-
tribution, and issuing of the stipulated documenta-
tion.
The acceptance phase of distribution in shipping of
biological pharmaceutical products in air transport is
characterized by the activities and procedures related
to handling terminals (airports) and carriers, i. e. con-
tracted legal subjects authorized to provide cargo han-
dling services. The procedures and activities included
in this phase can be recognized combined into two ba-
sic ones. Physical and documentary acceptance carry-
ing out the supervision activities based on the control
lists designed in order to check and confirm applica-
tion of all the valid regulatory issues defined for the
shipment of this type of transport entities. The pro-
cessing of a transport entity in order to determine and
document the compliance with the valid provisions
regulated for the respective entity, represents the key
step within the technological phase since the latter is
related to the very safety of air transport. The control
of the physically present entity and the accompanying
documents using the stipulated and by the carrier de-
signed control list, has the purpose of recognizing pos-
sible failures that may have occurred during the prep-
aration phase of entity processing, and can claim
through documents the preparedness of the transport
entity to be forwarded to the next phase. The mini-
mum of conditions contained in the control list are
stipulated by IATA, but the carriers may be more re-
strictive regarding the handling conditions. The super-
vision activities with the application of the control list
are performed by the authorized employees qualified
and licensed by IATA authorized training centres,
companies or legal persons. The qualification and li-
cense to perform dangerous cargo handling proce-
dures mean completed training course and passed cat-
egory 6 exam according to IATA category classifica-
tion relating to dangerous goods handling. The super-
vision activities based on adequate control list are car-
ried out by the carrier agents, on whose flights the
transport task is to be realized. This role may be taken
over also by the authorized employees of the handling
terminals or third parties provided they have the re-
quired qualifications so that there is contractually reg-
ulated relation to perform the activities included in
this scope.
The next phase in the technological process can be
unified under the common title dispatch activities.
The latter phase, as well as the previous one, is charac-
terized by the interaction between the handling termi-
nal and the carrier, and it refers, in the first place to
the application of the valid regulations related to the
technology of dispatch, as well as possible specific
characteristics related to this type of dispatch and in-
dividual carriers. In the first place, one may recognize
here the restrictions a carrier may have regarding dis-
patch of this type of entity. The restrictions may be
technical (aircraft type planned for individual trans-
port segments) or of technological character (regu-
lated obligation of fixing the transport entity within
the aircraft cargo compartment).
The last phase of the distributive process which re-
fers to the realization of the transport task is the trans-
port of the entity under the conditions defined and re-
quired by the shipper. The biologically produced
pharmaceuticals are characterized by their time and
temperature sensitivity. This is the reason for strict na-
tional and international regulations in the area of dis-
tribution as the precondition of preserving the original
quality of the products until they reach the end user.
The international regulations in the distribution of
temperature sensitive and restrictive pharmaceuticals
clearly emphasises the need to maintain the given con-
ditions during the distributive process. The WHO
document “Technical Report Series”, No. 917, Annex 2,
“Good trade and distribution practices for pharmaceuti-
cal starting materials”, in the Section Distribution and
Transport defines the expectations of the regulatory
bodies in the area of transport. The transport of clini-
cal materials shall be organized so that it shall guaran-
tee compliance with the given conditions. The trans-
port process shall not affect the quality of the trans-
port entity 3.
The European Medicines Agency, in the document
Guidelines on Good Distribution Practice of Medicinal
Products for Human Use 94/C 63/03, (these guidelines
have been prepared in accordance with Article 10 of
Council Directive 92/25/EEC of 31 March 1992 on the
wholesale distribution of medicinal products for human
use), defines precisely the transport conditions for tem-
perature sensitive and restrictive pharmaceutical prod-
ucts. Medicinal products as transport entities shall be pro-
tected during transport from negative impacts of tempera-
ture, light, moisture or other harmful influences 4.
Apart from the mentioned one, the European reg-
ulation contains also documents closely related to the
distribution of biological substances. Directive
2005/28/EC defines the conditions of product registra-
tion and import of clinical specimens and the
2002/98/EC Directive of quality and safety standards
for the collection, testing, processing, storage and dis-
tribution of human blood and blood components. The
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2004/23/EC Directive defines the standards of quality
and safety in collecting, testing, processing, storage
and distribution of human tissues and cells.
The United States Pharmacopeia (USP), in the
document: “General Chapter 1079 Good Storage and
Shipping Practice” emphasises the temperature re-
gime management in the distribution environment as
the crucial element of the original product quality as-
surance: the mentalities within the technological pro-
cess of distribution shall insure storage and transport
conditions with the objective of protecting the trans-
port entity under the conditions defined by the manu-
facturer 5.
The regulations in the Republic of Croatia are de-
fined in the 2008 Act on Medicinal Products which in
the section of general provisions emphasises the liabil-
ities of the distribution chain participants not exclud-
ing any of the mentalities within the technological pro-
cess of distribution 6.
5. DOCUMENT FOR COORDINATION
OF TRANSPORT ACTIVITIES AND
EPIDEMIOLOGICAL PROTECTION
SERVICE
The Act on Dangerous Goods Transport from July
2007, Article 28, Items 2 and 3 define the obligation to
appoint an expert counsellor as well as the obligation to
keep register of the employees qualified and licensed
to perform the activities of expert counsellor in the
area of handling dangerous cargo in air traffic. This Act
does not plan for the register of qualified and licensed
employees employed by the foreign carriers, nor the
register of employees qualified and licensed either in
Croatia or abroad, for handling perishable cargo in air
traffic. It may therefore be concluded that there is no
central register of the qualified and licensed employ-
ees for the handling of dangerous or perishable cargo
in air traffic in the Republic of Croatia.
The central register of the available number of li-
censed employees may represent an advantage in the
organization and implementation of the protection
measures in case of a pandemic in a certain region.
Apart from this data, the data on the available refrig-
eration capacities for individual handling terminals
may also be assessed as significant. For instance, the
distribution of vaccines by aircraft to Split may be as-
sessed as a demanding task since the refrigeration ca-
pacities of the handling terminal are limited. In such
circumstances the alternative solutions result from the
need to improvise which may represent a risk. Table 2
shows data on the capacities of refrigeration chambers
at cargo terminals of three busiest airports in Croatia,
obtained by carrying out a survey among the handling
services managers during March 2009.
Table 2 – Data on available refrigeration capacities













YES / 1 x 30m2 and
1 x 25m2
YES / 16m2
Source: Questionnaires filled in by managers of the authorized services
Information on temperature profiles of cargo
holds of individual aircraft types are also subject to
limited knowledge. In Croatia up to now no analysis
has been carried out nor any determining of tempera-
ture profiles of the aircraft cargo holds of the national
flag carrier. Similarly, no research has been done nor
any determining of the temperature profiles of the
handling terminals. Based on these facts it may be
concluded that there is poor knowledge about the en-
vironment within which the temperature sensitive en-
tities are transported.
The epidemiological unit of the Croatian National
Institute of Public Health, as part of its activities, orga-
nizes and implements activities in the area of control
and prevention, as well as analysis and tracking of epi-
demiological occurrences on the territory of the Re-
public of Croatia. Among other things, new vaccines
are being tested and the distribution is coordinated
and supervised. Based on the invitation of the World
Health Organization to air carriers to provide capaci-
ties for the transport of both clinical specimens as well
as vaccines, a discussion may be started about the or-
ganization and preparedness of the air transport sys-
tem in Croatia to the occurrence and development of
a greater volume of transporting time and tempera-
ture sensitive transportation entities. Table 2 indicates
the limited available capacities for the acceptance of
temperature sensitive shipments at airport terminals
in Croatia.
The coordination of traffic with the activities of the
epidemiological unit could mean the founding and op-
eration of a body responsible for the registering and
monitoring of the available capacities in the infra-
structure, transport means and trained and licensed
staff. Such a body could work as part of the scope of
activities of the Civil Aviation Agency. The tasks of
the coordination body for emergencies would include:
– Analysis of the condition and keeping the register
of the available infrastructure for the handling of
temperature sensitive shipments and dangerous
cargo.
– Analysis of the condition and keeping the register
of the qualified and licensed logistic operators to
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perform activities in the area of handling tempera-
ture sensitive shipments and dangerous cargo.
– Analysis of the condition and keeping the register
of the qualification and licenses of the staff in han-
dling temperature sensitive shipments and danger-
ous cargo.
– Supervision of the implementation of the national
and international regulations in the area of han-
dling temperature sensitive shipments and danger-
ous cargo.
– Implementation of control over technological pro-
cesses and documentation stipulated for the han-
dling of temperature sensitive shipments and dan-
gerous cargo.
– Analysis of the condition of infrastructure at air-
ports in Croatia regarding the need to organize
quarantine.
– Making of the regulations regarding procedures in
emergency cases in air transport in case of pan-
demic outbreak.
– Coordination of activities with the epidemiological
unit of the Croatian National Institute of Public
Health.
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Planning, coordination, and
management system in
emergencies in air traffic
Emergency Department
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Figure 3 – Scope of activities of a possible coordination body in case of emergencies, of the Civil Aviation Agency
Source: Author
– Writing of reports on the performed supervision in
accordance with the Regulations on Procedures in
Emergencies in Air Traffic in case of pandemic
outbreak.
Supervision belongs to the group of basic activities
of the Civil Aviation Agency. The expansion of the su-
pervision to the area of preparedness in case of pan-
demic outbreak as well as reporting to the Epidemio-
logical unit can represent a valuable contribution to
the organization and implementation of the measures
for fighting the pandemic. Knowing the circumstances
within the distributive environment for temperature
sensitive shipments and shipments of dangerous
cargo, as well as total passenger and cargo flows, vari-
ous scenarios of emergencies may be forecast, thus ac-
tively contributing to finding good solutions.
The coordination and management of emergen-
cies in air traffic can be included into the scope of ac-
tivities of the Civil Aviation Agency with the recom-
mendation of producing a detailed Regulations on the
supervision of the implementation of adequate na-
tional and international regulations and recommen-
dations relating to air traffic under the conditions of a
pandemic outbreak.
6. CONCLUSION
The handling and transport of biological sub-
stances and vaccines is a complex technological pro-
cess. The temperature oscillations, vibrations, pres-
sure changes, exposure to light, are all part of regular
occurrences in the distributive environment of air traf-
fic. Temperature oscillations are a phenomenon
which is present not only in the environment of the
production, storage or manipulative infrastructure,
but also in the transport means during the realization
of the transport task. International regulatory bodies
stipulate minimal conditions in the distribution of
temperature sensitive pharmaceuticals. Companies
specialized for the definition and performance of
technological processes of transporting temperature
sensitive and perishable cargo define the recommen-
dations in the preparation, organization, implementa-
tion and document validation of the technological
processes. Each of the mentalities within the distribu-
tive chain shall provide and carry out the stipulated
standards in the distributive environment.
The biggest threat to controlled technological pro-
cess of transporting temperature sensitive or danger-
ous cargo is the human factor. The goal of the elabo-
rated quality control system in the defined operations
of the distribution of these entities is to forecast the
weak points of the system and to eliminate them. In
the circumstances of increased flow of this category of
transport entities it is possible to forecast also an in-
creased occurrence of irregularities, especially in case
of a lack of a developed operative plan of flow control
within individual segments of the distributive environ-
ment. Formation of a body within the Civil Aviation
Agency with the task of preparing and documenting
the procedures in case of emergencies can contribute
to greater efficiency of the total preparations for fight-
ing against pandemic. In regular circumstances, the
analysis of the total capacities and systemic monitor-
ing of this segment of air traffic may also be a contri-
bution to regular activities of the agency.
Air traffic on the Croatian market has no analytic
document for assessing the preparedness and adjust-
ment to the conditions of pandemic outbreak. The
recommendations for the adjustment of cargo traffic
system stipulated by the World Health Organization
are not being implemented. The technological solu-
tions for this type of transport entities at cargo han-
dling terminals are not in compliance with the interna-
tional regulations and recommendations. The infor-
mation technology system as support to the distribu-
tive environment in cargo traffic is obsolete or inexist-
ent. In such circumstances it may be concluded that
the system is characterized by a number of potentially
risky points, and as such can represent an aggravating
circumstance in the organization and implementation
of the measures to fight the pandemic.
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SAÃETAK
ZRAÈNI PRIJEVOZ I LOGISTIKA U PANDEMIJI
VIRUSA A(H1N1)
U travnju 2009. Svjetska zdravstvena organizacija ocjenju-
je raspoloãive podatke o virusu svinjske gripe A(H1N1), potvr-
ðuje njegovo širenje i objavljuje odluku o podizanju faze pan-
demije influence sa pete na šestu. Meðunarodna udruga zrako-
plovnih prijevoznika upuæuje poziv zraènim prijevoznicima na
pruãanje podrške referentnim laboratorijima Svjetske zdrav-
stvene organizacije u prihvatu i otpremi, te zraènom prijevozu
bioloških uzoraka u sluèaju daljnjeg širenja pandemije. Zraèni
prijevoz bioloških uzoraka odvijati æe se prema uvjetima defini-
ranim za prihvat i otpremu opasnih tereta. U radu je analizi-
rana situacija u Republici Hrvatskoj i ustanovljeno je da ne
postoje infrastrukturne pretpostavke za prihvat i otpremu tak-
vih pošiljaka u svim zraènim lukama, licencirano osoblje,
koordinacija sa nadleãnim javnim zdravstvenim institucijama,
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te se predlaãu aktivnosti kako bi se Republika Hrvatska pripre-
mila, u skladu sa meðunarodnim propisima, za provedbu mje-
ra za obranu od pandemije.
KLJUÈNE RIJEÈI
izbijanje pandemije, regulativa, preporuke, biološki uzorci, po-
druèja odgovornosti, prijevoz i logistika za biološke uzorke
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